A study examined the CCK levels of CSF in 287 subjects with AD and found high levels of CCK were associated with higher total CSF tau and p-tau181, associated with better cognition and more gray matter volumes in the posterior cingulate gyrus, parahippocampal gyrus, and medial prefrontal cortex. This evidence concerns the gene MAPT and Alzheimer disease.